Preliminary toxicity and prostate-specific antigen response of a Phase I/II trial of neoadjuvant hormonal therapy, 103Pd brachytherapy, and three-dimensional conformal external beam irradiation in the treatment of locally advanced prostate cancer•-Reference-Cited by-同舟云学术

Preliminary toxicity and prostate-specific antigen response of a Phase I/II trial of neoadjuvant hormonal therapy, 103Pd brachytherapy, and three-dimensional conformal external beam irradiation in the treatment of locally advanced prostate cancer•

Published:2002-01 Issue:1 Volume:1 Page:2-10
ISSN:1538-4721
Container-title:Brachytherapy
language:en
Short-container-title:Brachytherapy

Author:

Stock Richard G,Stone Nelson N

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology

Reference34 articles.

1. Patterns-of-failure analysis of patients with high pretreatment prostate-specific antigen levels treated by radiation therapy;Hanks;J Clin Oncol,1996

2. Prostate-specific antigen for pretreatment prediction and posttreatment evaluation of outcome after definitive irradiation for prostate cancer;Kuban;Int J Radiat Oncol Biol Phys,1995

3. Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer;Kupelian;Urology,1996

4. Radical radiation therapy in the management of prostate adenocarcinoma;Zeitman;J Urol,1994

5. Radical prostatectomy for adenocarcinoma of the prostate;Zeitman;Urology,1994

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Determining Combined Modality Dosimetric Constraints by Integration of IMRT and LDR Prostate Brachytherapy Dosimetry and Correlation with Toxicity;Advances in Radiation Oncology;2023-05

2. Development of an adjoint sensitivity field-based treatment-planning technique for the use of newly designed directional LDR sources in brachytherapy;Physics in Medicine and Biology;2012-02-01

3. Radiation Therapy for Prostate Cancer;Campbell-Walsh Urology;2012

4. Prostaglandin F2α Represses IGF-I-Stimulated IRS1/Phosphatidylinositol-3-Kinase/AKT Signaling in the Corpus Luteum: Role of ERK and P70 Ribosomal S6 Kinase;Molecular Endocrinology;2010-03-01

5. Cell Migration in BeWo Cells and the Role of Epithelial Sodium Channels;Journal of Membrane Biology;2009-11-13